Benign Prostatic Hyperplasia, or BPH, is a condition in which the prostate enlarges as men age. BPH is very common, affecting nearly 40 million Americans and 500 million men worldwide. More than 40% of men in their 50s and more than 70% of men in their 60s have BPH.1 While BPH is a benign condition and unrelated to prostate cancer, it can greatly affect a man's quality of life.
The UroLift® System treatment offers rapid, lasting relief from BPH. Tiny implants are used to hold open the obstructed pathway that blocks urine flow. Unlike medications, the UroLift System treatment addresses the blockage directly, offering a mechanical solution to a mechanical problem.
Most men living with BPH symptoms take prescription medications after they’re diagnosed, although these often don’t provide adequate relief and may cause dizziness, fatigue, and sexual dysfunction.2
The UroLift System is a treatment option for men looking for relief from BPH symptoms. It does not require ongoing medication, heating, cutting or removal of prostate tissue, and the UroLift System treatment typically takes less than one hour.3
A wide variety of treatments are available for men with BPH, including medication, minimally invasive therapies, and surgery. You and your doctor will consider several factors when you evaluate these choices.
We are committed to assisting patients and their healthcare providers to navigate the insurance process. The UroLift System has 100% national Medicare coverage and is covered by most major private payors, now with more than 220 million covered lives.
The International Prostate Symptom Score (IPSS) is a common method for screening and diagnosing benign prostatic hyperplasia (BPH). The survey asks seven urinary symptom questions and one quality of life question to help determine the severity of your BPH.